Thomas Sinkjær

2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark.

National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD.

The Danish Cancer Society provides support and resources for those affected by cancer, including patients and their families. The non-profit company is based in Copenhagen, Denmark and has subsidiaries in Denmark. The Danish company offers the latest information on patient involvement in cancer treatment and tools for utilizing patient-reported information. The organization also promotes cancer prevention through screening and works towards reducing the number of cancer cases and improving the quality of life for those who have survived cancer.

Gibson Oncology LLC composes proven academic researchers and bio tech entrepreneurs. The firm also develops novel oncology drugs to treat resistant cancers with a focus on children. The company was founded by Mark C. Rogers, Theodore C, Solomon, Cliff T. Solomon and Elizabeth L. Rogers and is headquartered in Miami, FL.

CytoTrack ApS engages in the provision of medical scanners for rare cell detection systems. Its products include CytoTrack CT11 scanner, CytoDisk and CytoCover, and CytoTrack reagent kit. The company was founded by Christian Caspersen, Tom Hede Markussen and Lars Ulrik Nielsen in 2004 and is headquartered in Lyngby, Denmark.

EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark.

Istituto Europeo di Oncologia SRL is a holding company, which operates oncology hospitals. It offers healthcare services, basic and translational cancer research, and PhD and post doctoral programs in molecular medicine. The company was founded by Umberto Veronesi on May 30, 1994 and is headquartered in Milan, Italy.

TKS A/S provides tongue control system device for disabled people. The firm develops and markets assistive device solutions based on core technology intervention - wireless tongue control. The company is headquartered in Aalborg, Denmark.

AnyBody Technology A/S develops software for computer analysis of the working human body. It offers consulting services, training, and support. The firm serves in the area of orthopedics, automotive, assistive devices, aerospace, defense, ergonomics, consumer, sports and universities. The company was founded by Michael Damsgaard, Egidijus Surma, Søren Tørholm, Mark de Zee and John Rasmussen in December 2001 and is headquartered in Aalborg, Denmark.

GateHouse Holding A/S provides logistics data services. The company was founded by Michael Bondo Andersen in 1992 and is headquartered in Nørresundby, Denmark.

FORCE Technology provides technical consultancy services. The firm offers knowledge and technologies in the form of improved products, processes, and methods. It focuses on the following areas: energy, oil and gas, maritime, manufacturing, infrastructure, and services. The company was founded in 1939 and is headquartered in Brondby, Denmark.

Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark.

ORIGIO A/S manufactures and markets assisted reproduction technologies and related human reproductive products. Its products include Andrology, sequential series, EmbryoGem, BlastGen, Pipettes, ICSI micropipets. The company was founded in 1987 and is headquartered in Maaloev, Denmark.

Aniona ApS is a private company based in Ballerup, Denmark. Jørgen Drejer has been the CEOs since incorporation. The Danish company was founded by Thomas Feldthus, Anker Gunvald Lundemose, Claus Tycho Bræstrup, Jørgen Drejer.

DELTA A/S is a testing and consulting private company based in Hørsholm, Denmark. DELTA A/S operates as a testing and consulting Danish company. The CEO of the company is Per Hartlev.

Part of Atonomics A/S, Azign Bioscience AS is a biotechnology company based in Copenhagen, Denmark. The Danish company provides biotechnology services. Azign Bioscience was acquired by Atonomics A/S from NTG Nordic Transport Group A/S on June 30, 2004.

Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark.

Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark.

DELTA, Dansk, Elektronik, Lys & Akustik offers technical consultancy services in the fields of electronics, microelectronics, software technology, light, optics, acoustics, vibration and sensor systems. The company was founded by P.O. Pedersen in 1941 and is headquartered in Horsholm, Denmark.

Ellegaard Göttingen Minipigs A/S is a private company based in Dalmose, Denmark that develops, breeds, and supplies Göttingen Minipigs for biomedical research worldwide. The Danish company's fundamental belief in quality, cooperation, respect, and animal welfare enables the development of safer and more effective medicines. Ellegaard Göttingen Minipigs supplies Göttingen Minipigs of all ages, weight groups, and both genders for biomedical research. The company's barrier facilities ensure breeding of Göttingen Minipigs of high quality and with a unique health status. Supporting and participating in scientific research activities involving Göttingen Minipigs is a fundamental part of the business foundation at Ellegaard Göttingen Minipigs. The CEO of the company is Lars Friis Mikkelsen.

Part of Saniona AB, Saniona A/S is a Danish company dedicated to improving the lives of rare disease patients worldwide through scientific innovation. The company focuses on Prader-Willi Syndrome, a rare genetic disorder characterized by insatiable appetite, abnormal growth and body composition, low muscle tone, and social/emotional/cognitive deficits. Saniona is a leader in the discovery of highly specific ion channel modulators, which is a validated approach to treating diseases such as diabetes, hypertension, and epilepsy. The company's robust ion channel drug discovery engine has led to the development of San711, a first-in-class positive allosteric modulator of GABAA ?3 receptors, and San903, a potential first-in-class inhibitor of the calcium-activated potassium ion channel, KCA3.1, both of which are in development for rare neuropathic, inflammatory, and fibrotic disorders.

MonTa Biosciences ApS engages in research and development in biotechnology for cancer immunotherapy. Its technology offers a solution to deliver immune stimulating compounds directly to immune cells in the blood. The company was founded by Thomas Lars Andresen, Jonas Henriksen, and Simon Skjøde Jensen in August 2014 and is headquartered in Brønshøj, Denmark.

Calum Ejendomsinvest A/S develops and leases out real estate. The company is headquartered in Aalborg, Denmark.